<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>280</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11183781</PubmedId>
            <Abstract>Outer surface protein A (OspA) is a major lipoprotein of the Borrelia burgdorferi spirochete, the causative agent of Lyme disease. Vaccination with OspA generates an immune response that can prevent bacterial transmission to a mammalian host during the attachment of an infected tick. However, the protective capacity of immune sera cannot be predicted by measuring total anti-OspA antibody. The murine monoclonal antibody LA-2 defines an important protective B-cell epitope of OspA against which protective sera have strong levels of reactivity. We have now mapped the LA-2 epitope of OspA using both NMR chemical-shift perturbation measurements in solution and X-ray crystal structure determination. LA-2 recognizes the three surface-exposed loops of the C-terminal domain of OspA that are on the tip of the elongated molecule most distant from the lipid-modified N terminus. The structure suggests that the natural variation at OspA sequence position 208 in the first loop is a major limiting factor for antibody cross-reactivity between different Lyme disease-causing Borrelia strains. The unusual Fab-dominated lattice of the crystal also permits a rare view of antigen flexibility within an antigen:antibody complex. These results provide a rationale for improvements in OspA-based vaccines and suggest possible designs for more direct tests of antibody protective levels in vaccinated individuals.</Abstract>
            <ArticleYear>2000</ArticleYear>
            <ArticlePages>1153-64</ArticlePages>
            <ArticleTitle>Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Ding</LastName>
                    <ForeName>W</ForeName>
                </Author>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>X</ForeName>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>X</ForeName>
                </Author>
                <Author>
                    <LastName>Dunn</LastName>
                    <ForeName>J J</ForeName>
                </Author>
                <Author>
                    <LastName>Luft</LastName>
                    <ForeName>B J</ForeName>
                </Author>
                <Author>
                    <LastName>Koide</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Lawson</LastName>
                    <ForeName>C L</ForeName>
                </Author>
            </Authors>
            <Affiliations>Biology Department, Brookhaven National Laboratory, Upton, NY 11973, USA.</Affiliations>
            <ArticleChemicalList>Antigen-Antibody Complex;Antigens, Bacterial;Antigens, Surface;Bacterial Outer Membrane Proteins;Bacterial Vaccines;Epitopes, B-Lymphocyte;Immunoglobulin Fab Fragments;Lipoproteins;Lyme Disease Vaccines;OspA protein</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Antigen-Antibody Complex(chemistry; immunology); Antigens, Bacterial(chemistry; genetics; immunology); Antigens, Surface(chemistry; genetics; immunology); Bacterial Outer Membrane Proteins(chemistry; genetics; immunology); Bacterial Vaccines; Borrelia burgdorferi Group(chemistry; genetics; immunology); Crystallography, X-Ray; Epitope Mapping; Epitopes, B-Lymphocyte(chemistry; genetics; immunology); Genetic Variation(genetics); Immunoglobulin Fab Fragments(chemistry; immunology); Lipoproteins; Lyme Disease(immunology); Lyme Disease Vaccines(chemistry; genetics; immunology); Models, Molecular; Molecular Sequence Data; Mutation; Nuclear Magnetic Resonance, Biomolecular; Protein Structure, Secondary; Protein Structure, Tertiary; Sequence Alignment</ArticleMeshHeadingsList>
            <Journal>
                <Volume>302</Volume>
                <Issue>5</Issue>
                <Title>Journal of molecular biology</Title>
                <Issn>1089-8638</Issn>
                <MedlineTa>J Mol Biol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>LA-2 Fab epitope on OspA</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>S206, S207, A208, A209, T210, K211, K212, T213, A214, A215, T226, V227, N228, S229, K230, K231, D249, S250, N251, G252, T253</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>P0CL66.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>139</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 2 and PDB 1FJ1</LocationOfData>
                <EpitopeId>190616</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 2, 3, Table 1 and PDB 1FJ1</LocationOfData>
                        <BCellId>33</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P0CL66.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>139</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The details of the immunization procedure were not described. The mAb is stated to be specific for OspA of Borrelia burgdorferi B31 in Wilske et al. (1988) Ann N Y Acad Sci 539:126-143 [PMID: 2461135].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.68</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of LA-2 Fab on OspA was determined from the crystal structure of the complex solved by molecular replacement. There are two identical Fab-antigen complexes in the asymmetric unit with chains (A,B,F) and (C,D,E). The first one is curated.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>LA-2</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2b</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>LA-2</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1FJ1_B</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1FJ1_A</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P0CL66.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>139</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1FJ1</ComplexPdbId>
                            <AntibodyChain1PdbChain>B</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>A</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>F</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>Paratope residues and antigen-antibody contacts are not provided in the paper. There is only mention that the interactions between OspA and LA-2 include 8 direct H-bonds, 4 solvent-bridged hydrogen bonds, and 3 ion pairs. The crystal structure contains two identical complexes in the asymmetric unit. The mAb 336 epitope does not overlap with LA-2 epitope. Both are located in the C-terminal region of OspA. The MAb 184.1 epitope is located in the N-terminal of OspA [PDB: 1OSP].</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>F: S206, S207, A208, A209, T210, K211, K212, T213, A214, A215, T226, V227, N228, S229, K230, K231, D249, S250, N251, G252, T253;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>A: ; B: ;</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>733.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>752.0</ContactAreaForAntibody>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>F: S206, S207, A208, A209, K211, T213, A214, A215, T226, N228, S229, K230, D249, S250, N251, G252, T253</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>A: Y32, L46, H49, Y50, T53, L54, Q55, P56, Y91, L94, R96; B: T30, D31, Y32, S33, I51, N52, T53, E54, R98, G99, L100, D101</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>872.1</ContactAreaForAntigen>
                                <ContactAreaForAntibody>755.1</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <BCellId>2012290</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P0CL66.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>139</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The details of the immunization procedure were not described. The mAb is stated to be specific for OspA of Borrelia burgdorferi B31 in Wilske et al. (1988) Ann N Y Acad Sci 539:126-143 [PMID: 2461135].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>130</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The contact residues of epitope-specific of LA-2 Fab on OspA were determined by NMR chemical shift perturbation. The study identified 49 residues that are significantly affected  upon binding of LA-2 Fab to OspA and included the contact residues determined by the crystal structure. Residues affected by LA-2 binding included residues 184, 186, 203-220, 224-233 and 246-257. Witihin these regions, residues 206, 216, 207, and 227 were excluded.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>LA-2</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2b</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>LA-2</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1FJ1_B</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1FJ1_A</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P0CL66.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>139</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

